IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.937
AS - Asia 4.736
EU - Europa 4.302
SA - Sud America 686
AF - Africa 83
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.831
CN - Cina 2.813
IE - Irlanda 1.071
SG - Singapore 954
DE - Germania 642
UA - Ucraina 639
BR - Brasile 580
FI - Finlandia 578
HK - Hong Kong 486
RU - Federazione Russa 476
SE - Svezia 238
IT - Italia 215
GB - Regno Unito 211
VN - Vietnam 194
FR - Francia 70
CA - Canada 69
IN - India 65
AR - Argentina 38
BD - Bangladesh 38
ZA - Sudafrica 33
JP - Giappone 30
BE - Belgio 29
TR - Turchia 28
ID - Indonesia 27
MX - Messico 23
NL - Olanda 23
EC - Ecuador 22
ES - Italia 21
IQ - Iraq 20
PL - Polonia 20
PE - Perù 14
EG - Egitto 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
PY - Paraguay 10
PK - Pakistan 9
AT - Austria 8
JO - Giordania 8
LT - Lituania 8
MU - Mauritius 8
VE - Venezuela 8
IL - Israele 7
MA - Marocco 7
CO - Colombia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
KZ - Kazakistan 5
MK - Macedonia 5
TN - Tunisia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PT - Portogallo 4
SA - Arabia Saudita 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
DZ - Algeria 3
GE - Georgia 3
NO - Norvegia 3
PA - Panama 3
SN - Senegal 3
AU - Australia 2
BG - Bulgaria 2
DJ - Gibuti 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
LV - Lettonia 2
MG - Madagascar 2
NC - Nuova Caledonia 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
IM - Isola di Man 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 15.745
Salva come PNG Salva come JPEG
Città #
Dublin 1.071
Chandler 894
Jacksonville 848
Nanjing 655
Dallas 536
Hong Kong 486
Singapore 420
Beijing 407
Ashburn 382
Boardman 327
Nanchang 287
Munich 204
Shenyang 200
Princeton 194
Lawrence 190
Medford 186
Helsinki 185
Hebei 180
Wilmington 173
Changsha 171
Jiaxing 162
Los Angeles 148
Hangzhou 110
Tianjin 102
Ann Arbor 90
Redondo Beach 88
Moscow 86
Buffalo 77
Shanghai 77
Ho Chi Minh City 69
São Paulo 59
New York 53
Woodbridge 53
Cambridge 51
Turku 50
Milan 41
Seattle 40
Hanoi 38
Toronto 38
Piscataway 31
Pavia 28
Brussels 27
Santa Clara 27
Fairfield 26
Pune 25
Tokyo 25
Johannesburg 24
Norwalk 24
Des Moines 22
Jinan 22
Rio de Janeiro 22
Kunming 21
Montreal 20
Guangzhou 19
San Francisco 19
Brooklyn 18
Stockholm 18
The Dalles 18
Verona 17
London 16
Belo Horizonte 15
Chennai 15
Chicago 14
Falkenstein 14
Orem 14
Frankfurt am Main 13
Ankara 12
Atlanta 12
Boston 12
Charlotte 12
Denver 12
Taizhou 12
Zhengzhou 12
Campinas 11
Ningbo 11
Orange 11
Tashkent 11
Warsaw 11
Washington 11
Phoenix 10
Quito 10
Curitiba 9
Dhaka 9
Houston 9
Poplar 9
Salvador 9
Baghdad 8
Brno 8
Fuzhou 8
Haiphong 8
Trujillo 8
West Jordan 8
Amman 7
Berlin 7
Brasília 7
Bắc Ninh 7
Eindhoven 7
Jakarta 7
Porto Alegre 7
Columbus 6
Totale 10.300
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 230
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 165
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 138
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 133
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 129
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 124
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 122
RAGE : a central player in nondiabetic vascular disease 120
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 118
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 118
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 117
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 110
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 109
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 109
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 109
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 108
Abscisic Acid Treatment in Patients with Prediabetes. 107
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 106
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 106
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 104
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 104
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 104
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 103
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 103
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 103
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 102
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 102
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 99
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 99
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 98
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 98
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 98
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 97
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 97
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 97
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 96
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 96
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 96
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 95
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 94
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 94
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 94
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 93
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 93
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 92
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 91
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 91
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 91
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 91
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 90
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 90
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 90
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 90
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 90
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 89
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 89
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 89
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 89
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 88
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 88
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 88
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 88
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 88
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 87
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 87
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 87
Effects of berberine on lipid profile in subjects with low cardiovascular risk 86
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 86
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 86
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 86
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 85
Candesartan effect on inflammation in hypertension 84
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 83
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 83
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 83
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 82
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 82
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 82
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 81
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 81
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 81
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 80
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 80
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 79
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 78
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 78
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 77
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 77
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 77
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 76
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 76
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 76
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial 76
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 75
La terapia con rosiglitazone migliora i parametri di insulino-resisitenza nei pazienti diabetici in sovrappeso ed obesi intolleranti alla metformina 75
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 75
Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients 75
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 75
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 74
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin 74
Totale 9.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021784 0 0 0 0 0 160 9 187 43 186 157 42
2021/2022740 12 4 30 5 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20263.291 551 420 831 714 730 45 0 0 0 0 0 0
Totale 15.984